Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – November 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV), a company pioneering its patented Botanical Synthesis technology platform, today announcedthat management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December […]

Vancouver, British Columbia and Rehovot, Israel – November 18, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2024 after market close on Monday, November 25, 2024. Management

Vancouver, British Columbia and Rehovot, Israel – November 12, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST) (CSE: BHSC), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company’s shares will begin trading on the Nasdaq Global Market (“Nasdaq”) at the opening of the U.S. market today under the

Vancouver, British Columbia and Rehovot, Israel – October 28, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology process, today announced the appointment of Bar Dichter (née Moreh)  as Chief Financial Officer of the Company. Ms. Dichter joined the Company as Controller in

Management Guides Fourth Quarter Revenues to Grow to at Least $7.2 Million USD; Reaffirms Goal to Complete Nasdaq Uplisting by Year-End Vancouver, British Columbia and Rehovot, Israel – October 23, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology process,  today preannounced preliminary financial